CEO Michael Pearson
From The Press
Valeant Pharmaceuticals (VRX) to Name New CEO as Pearson Still in Hospital
Valeant Pharmaceuticals International Inc (NYSE:VRX) is considering to name a new chief executive to lead the company while Michael Pearson is still in the hospital due to severe pneumonia, according to the Wall Street...
From The Press
Bill Ackman Still Confident with Valeant Pharmaceuticals (VRX) CEO
Bill Ackman, the head of Pershing Square Capital Management, is still confident with the leadership of Michael Pearson, the CEO of Valeant Pharmaceuticals (NYSE:VRX) although the company’s stock price continues to slide amid allegations...
